Hormonal control of energy metabolism
Hormonal Control of Energy Metabolism
Course Code: HUF2-110
Academic Year: 2025-26
Overview of Content
Hormonal control of energy metabolism
List of hormones
Major target tissues
Metabolic processes
Reasons for regulation
Fed/anabolic state
Fasting/catabolic state
Body defense against hypoglycemia
Processes and hormones involved
Counter-regulatory hormone response to insulin-induced hypoglycemia (early/later response; synergistic interaction)
Diabetes mellitus
Classification
Comparisons between type 1 and type 2 diabetes mellitus
Diagnostic criteria of diabetes and pre-diabetes
Proposed etiology of type 2 DM and deterioration of β-cell function
Molecular mechanism of insulin resistance
Hormones Involved
Insulin
Glucagon
Epinephrine
Cortisol
Growth Hormone
Metbolic Processes Involved
Glycogen synthesis
Lipid synthesis
Protein synthesis
Glycogenolysis
Gluconeogenesis
Lipolysis
Ketogenesis
Proteolysis
Major Organs Involved
Liver
Adipose tissue
Muscle
Summary of Normal Hormonal Influences on Metabolism
Effects of Hormones
Insulin
Stimulates glucose uptake by cells.
Stimulates amino acid uptake by cells.
Stimulates glucose catabolism for energy.
Stimulates glycogenesis.
Stimulates lipogenesis and fat storage.
Inhibits gluconeogenesis.
Stimulates protein synthesis (anabolic).
Glucagon
Stimulates glycogenolysis.
Stimulates lipolysis and fat mobilization.
Stimulates gluconeogenesis.
Stimulates protein breakdown (catabolic).
Epinephrine
Similar effects to glucagon in increasing glucose production and mobilization of fats.
Cortisol
Increases gluconeogenesis.
Increases proteolysis and lipolysis.
Growth Hormone
Supports gluconeogenesis and promotes lipolysis.
Regulation of Energy Metabolism
Fed/Anabolic State
Effects of Insulin:
Increase glucose and amino acid uptake.
Increase glycolysis (glucose utilization).
Increase glycogen synthesis in liver and muscle.
Increase lipogenesis in adipose tissue.
Increase protein synthesis in muscle.
Inhibition of catabolic processes.
Fasting/Catabolic State
Hormonal Control:
Controlled by glucagon, epinephrine, GH, and cortisol.
Energy Supply to the Body:
Origin of Fuel:
Liver: Glycogen, glucose, gluconeogenesis.
Muscle: Amino acids from muscle, lactate from RBCs.
Adipose tissue: Triglycerides, fatty acids, glycerol.
Fuel Consumption:
Increase in glucose production through glycogenolysis and gluconeogenesis.
Decrease in glucose utilization by insulin-responsive tissues.
Increased lipolysis and ketogenesis for energy.
Body Defense Against Hypoglycemia
Counter-Regulatory Hormones
Hormones that counter-regulate against the hypoglycemic effect of insulin.
Types of Responses:
Some hormones respond early while others respond later, depending on the degree of hypoglycemia.
Actions include stimulating glycogenolysis, gluconeogenesis, and lipolysis.
Recommendations for Management of Hypoglycemia
Intravenous infusion of glucose:
Dextrose solution.
Injection of glucagon:
Stimulates glycogenolysis and gluconeogenesis.
Oral intake of glucose:
Candy, fruit juice, or bananas.
Diabetes Mellitus
Classification
Diabetes Mellitus is characterized by:
Hyperglycemia resulting from defects in insulin secretion, insulin action, or both.
Types:
Type 1 Diabetes Mellitus (T1DM):
Caused by an absolute deficiency of insulin due to β-cell destruction.
Previously referred to as insulin-dependent diabetes or juvenile-onset diabetes.
Type 2 Diabetes Mellitus (T2DM):
Caused by a combination of insulin resistance and a progressive loss of adequate β-cell insulin secretion.
Previously referred to as non-insulin dependent diabetes or adult-onset diabetes.
Specific Types of Diabetes:
Due to other causes or drug-induced (e.g., glucocorticoid use, GH excess).
Gestational Diabetes:
Progression of T2DM:
Patients may undergo compensatory increase in insulin secretion prior to β-cell failure.
Eventually, may require insulin injections to maintain blood glucose levels.
Diagnosis of Diabetes Mellitus
Symptoms:
Polyuria, polydipsia, unexplained weight loss.
Diagnostic Criteria:
Fasting plasma glucose (FPG) levels ≥7.0 mmol/L.
2-hour post 75 g OGTT plasma glucose ≥11.1 mmol/L.
Hemoglobin A1C >6.5%.
Random plasma glucose ≥11.1 mmol/L.
Proposed Etiology of Type 2 Diabetes Mellitus
Obesity:
Especially visceral fat as a major contributing factor to insulin resistance via TNF-α, resistin, and free fatty acids (FFA).
Visceral fat influences hepatic metabolism directly through the hepatic portal circulation.
Hyperinsulinemia's Role:
Developed in response to hyperglycemia, worsens insulin resistance through receptor downregulation and desensitization.
Deterioration of β-cell Function:
Results from glucotoxicity and lipotoxicity (including oxidative stress and reactive oxygen species).
Molecular Mechanisms of Insulin Resistance
Decreased Insulin Receptors:
Loss in density or number due to cell size increase.
Lipid Accumulation:
High caloric intake leads to formation of lipotoxic precursors.
DAG activates PKC, which decreases insulin signaling efficiency.
Fatty Acyl-CoA Entry into Cells:
Causes inadequate cellular oxidation and lipid droplet accumulation, leading to further signaling interference.
Physiological Adaptation to Starvation
Metabolic Response:
Shift from carbohydrate to fat metabolism.
Initially depletes carbohydrate stores (glycogen).
Prolonged Starvation Effects:
Increase in ketogenesis and reliance on fat-derived fuels during extended periods without food.
References
Starvation: Metabolic Changes.
Dermatological changes and protein metabolism affected during prolonged starvation.
Diabetes Classification: American Diabetes Association (ADA) standards.
Note: Detailed citations and URLs of resources used in the material can be added as needed.